Side-by-side comparison of AI visibility scores, market position, and capabilities
Roche subsidiary and founding biotech; invented the biologics industry with recombinant DNA. Blockbuster oncology franchise includes Herceptin, Avastin, Rituxan, and Tecentriq.
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching the modern biotechnology industry. Acquired by Roche in 2009 for $46.8 billion, Genentech continues to operate with significant R&D autonomy as the US hub for Roche's pharmaceutical innovation.\n\nThe company is best known for pioneering cancer biologics, developing Herceptin (trastuzumab) for HER2-positive breast cancer, Avastin (bevacizumab) for multiple cancers, Rituxan (rituximab) for lymphoma, and Tecentriq (atezolizumab) for PD-L1 immunotherapy. Its discovery engine spans oncology, neuroscience, ophthalmology, and immunology with a robust early-stage pipeline leveraging AI-assisted target identification.\n\nGenentech generates tens of billions in annual revenue through Roche's Pharmaceuticals Division and remains one of the most productive biotech research sites in the world, consistently ranked among top employers in life sciences. The South San Francisco campus employs over 13,000 scientists, clinicians, and engineers, anchoring the Bay Area as a global biotech hub.
Tesla (TSLA) reported $97.7B revenue in FY2024, up 1% YoY. 1.8M vehicles delivered. Market cap ~$900B. 140,000+ employees. Austin, TX. FSD (Full Self-Driving), Optimus humanoid robot, Dojo AI training supercomputer.
Tesla is an electric vehicle and clean energy company founded in 2003 by Martin Eberhard and Marc Tarpenning in San Carlos, California, and subsequently co-founded and led by Elon Musk, who joined as chairman and lead investor in 2004. The company was built on the premise that electric vehicles could be desirable, high-performance automobiles — not compromise products — and that compelling EVs would accelerate the world's transition to sustainable energy. Musk's strategy, articulated in the 2006 "Secret Master Plan," was to start with a premium sports car (Roadster), use the proceeds to build a more affordable sedan (Model S), and ultimately produce a mass-market vehicle (Model 3). Tesla trades on Nasdaq under the ticker TSLA and has since expanded its mission to encompass solar energy, stationary storage, and autonomous driving.\n\nTesla's product portfolio spans the Model 3 (sedan), Model Y (compact SUV — the world's best-selling vehicle in 2023), Model S (premium sedan), Model X (premium SUV), Cybertruck (full-size electric pickup), and the Tesla Semi commercial truck. The company's energy business includes the Powerwall home battery, Megapack utility-scale storage, and Solar Roof installations. Tesla's Full Self-Driving (FSD) software suite provides driver assistance capabilities up to supervised autonomous driving, with a paid subscription and per-vehicle purchase option. Tesla operates a proprietary Supercharger network of 50,000+ charging stations globally, a significant infrastructure moat that has become accessible to competing EV brands through industry NACS adapter adoption.\n\nTesla reported FY2024 revenue of $97.7 billion, up approximately 1% year over year, with 1.8 million vehicles delivered and a market capitalization of approximately $900 billion — making it one of the ten most valuable companies in the world. The company employs 140,000+ people and operates Gigafactories in Austin (Texas), Fremont (California), Shanghai, Berlin, and Nevada. Despite increasing competition from BYD in China and European automakers globally, Tesla's vertical integration, software-defined vehicle architecture, FSD capability, and energy storage business position it as the defining company of the electric transportation and distributed energy era.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.